BioSpace News Archive

Evotec SE announced that the Company has launched an initiative for pandemic preparedness.

Vicore Pharma Holding AB, a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis, announces the participation in two upcoming investor meetings in June 2021.

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, managed to successfully continue its growth in the fiscal year 2020 despite a challenging year overall.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy announced that they are collaborating on an expansive molecular characterization project for cellular therapies.

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, announced the appointment of Martijn Negen, MSc, MBA, as Vice President for Commercial Strategy.

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced the broad commercial launch of a SARS CoV-2 Neutralization Antibody Test.

Rising prevalence of blood-associated disorders and increased awareness about hematology diagnostics and treatments are expected to spur market growth.

MedX Health Corp. announces that, further to Acceptance from the TSX Venture Exchange, it has issued 360,000 common shares at a deemed issue price of $0.20 per share, representing a total consideration of $72,000, as compensation for consulting services rendered.

Viva Biotech declared that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company unlocking the potential of proteins as next-generation therapeutics.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Magenta Investments, a leading pharmaceutical and healthcare company that is part of an investment and industrial conglomerate in the United Arab Emirates (UAE), today announced a new agreement to distribute the Moderna COVID-19 Vaccine